Vinge has advised Santander Consumer Bank AS in connection with the sale of its Swedish and Norwegian credit card business as well as the sales financing business that Santander currently operates in partnership with Elkjøp in Norway and Elgiganten in Sweden to Avida Finans AB (publ).
Vinge has advised the energy technology company Flower Infrastructure Technologies AB (“Flower”) in the acquisition of one of Sweden's largest battery storage projects, Pajkölen, from Arise AB (publ) (“Arise”). The project, which is a 40 MW / 80 MWh Ready-to-Build battery energy storage system (BESS), is located in the Kölvallen wind farm in Ljusdal municipality. The transaction comprise all shares in Pajkölen BESS AB, which owns all rights to the project.
Vinge has advised the Nordic private equity firm Axcel in connection with its establishment of a new property well-being service group by creating a platform of 15 companies across Sweden and Norway. The group offers inspection, maintenance and incident management services for properties, with a focus on indoor air quality, moisture and pipes.
Vinge has advised Consolid Equity Investment AB (“Consolid Equity”) in connection with the establishment of the Road Mobility Services Group through the consolidation of 28 tire and towing companies.
Vinge has, together with Kirkland & Ellis, advised Zellis Group, a portfolio company of funds advised by Apax Partners LLP (“Apax”), in connection with the acquisition of Benify, a provider of employee benefits administration software, from Vitruvian Partners and the other shareholders.
Vinge has, together with Kirkland & Ellis, advised Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the healthcare and industrial sectors, in connection with the acquisition of seven manufacturing and development facilities in Sweden, France, and Spain, from Recipharm Group, a contract development and manufacturing organization (“CDMO”) headquartered in Stockholm.
Vinge has advised Fidelio Capital (“Fidelio”) and the other shareholders of Odevo Group (“Odevo”) in connection with the divestment of a minority shareholding to funds controlled by CVC Capital Partners (“CVC”). Fidelio, the existing management team and other minority shareholders of Odevo will retain a majority holding in the company.
Vinge has advised IK Partners and the other owners in connection with the divestment of Carspect Group Holding AB to TÜV SÜD Aktiengesellschaft. Carspect is a leading provider of vehicle inspections in Sweden, Estonia and Latvia, with a total of approximately 150 stations and over 500 employees.
Vinge advises Bridgepoint Development Capital III and Bridgepoint Europe VI (”Bridgepoint”), founders as well as the other shareholders in connection with Cinven, an international private equity firm, acquiring a significant stake in Vitamin Well Group (“Vitamin Well”) and thereby becoming the new lead investor, while Bridgepoint, founders and the other shareholders will retain significant minority stakes following the transaction.
The energy storage facility Bredhälla consists of batteries utilizing lithium-ion technology with a total capacity of 42,5MW /42,5MWh spread across 20 modules, making it the largest battery park in Sweden. Bredhälla will provide ancillary services to Svenska Kraftnät to ensure stability in the electricity grid and participate in wholesale markets by providing energy arbitrage.
Lantmännen Cerealia has signed an agreement to divest its ready-to-eat business under the Gooh brand to Atria Sweden. The deal encompasses the entire business, as well as the Gooh brand. All staff currently working in the business area will be invited to join the transfer. The divestment means that Lantmännen Cerealia is focusing its operations on the grain value chain.
Vinge advises Santander Consumer Finance in connection with its acquisition of all shares in Athlon Sweden AB, which is part of Mercedes-Benz Mobility.
Vinge advises EQT Healthcare Growth, a new dedicated healthcare buy-out strategy introduced by EQT, in connection with its first investment – the acquisition of the biotech company, Mabtech, from IK Small Cap II Fund and several minority sellers.
